BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 237 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2020. The put-call ratio across all filers is 1.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $746,834 | +70.6% | 16,600 | +66.1% | 0.00% | +100.0% |
| Q4 2022 | $437,837 | +77.3% | 9,994 | +316.2% | 0.00% | 0.0% |
| Q3 2021 | $247,000 | -78.9% | 2,401 | -77.0% | 0.00% | -80.0% |
| Q4 2020 | $1,173,000 | -68.8% | 10,460 | -83.7% | 0.01% | -82.8% |
| Q1 2020 | $3,760,000 | -20.3% | 64,308 | +9.2% | 0.03% | -12.1% |
| Q4 2019 | $4,719,000 | +158.0% | 58,900 | +136.5% | 0.03% | +106.2% |
| Q3 2019 | $1,829,000 | +553.2% | 24,900 | +741.8% | 0.02% | +433.3% |
| Q2 2019 | $280,000 | +2.9% | 2,958 | -13.0% | 0.00% | 0.0% |
| Q1 2019 | $272,000 | -76.0% | 3,400 | -76.6% | 0.00% | -50.0% |
| Q3 2018 | $1,132,000 | -17.9% | 14,500 | -33.2% | 0.01% | -25.0% |
| Q2 2018 | $1,378,000 | +70.8% | 21,711 | +146.7% | 0.01% | +100.0% |
| Q1 2018 | $807,000 | +85.1% | 8,800 | -19.3% | 0.00% | +33.3% |
| Q1 2017 | $436,000 | +2080.0% | 10,900 | +990.0% | 0.00% | – |
| Q2 2016 | $20,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |